Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.
暂无分享,去创建一个
Edwin Wang | Catherine Collins | Chabane Tibiche | Mark Trifiro | Miltiadis Paliouras | Lei Li | E. Wang | M. Jaramillo | M. O’Connor-McCourt | C. Collins | Lei Li | Chabane Tibiche | A. Nantel | M. Paliouras | Naif Zaman | M. Trifiro | Andre Nantel | Naif Zaman | Maureen O'Connor-McCourt | Maria Luz Jaramillo | Zhanpeng Sun | Myriam Banville | M. Banville | Zhanpeng Sun
[1] Gary D Bader,et al. A travel guide to Cytoscape plugins , 2012, Nature Methods.
[2] Ji Luo,et al. Cancer Proliferation Gene Discovery Through Functional Genomics , 2008, Science.
[3] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Q. Cui,et al. Identification of high-quality cancer prognostic markers and metastasis network modules , 2010, Nature communications.
[5] James T. Webber,et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins - eScholarship , 2012 .
[6] G. Parmigiani,et al. Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing , 2012, Science Translational Medicine.
[7] Q. Cui,et al. Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network. , 2007, IET systems biology.
[8] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[9] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[10] L. Chin,et al. Making sense of cancer genomic data. , 2011, Genes & development.
[11] Edwin Wang,et al. Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance. , 2013, Seminars in cancer biology.
[12] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[13] M. Moran,et al. The human phosphotyrosine signaling network: Evolution and hotspots of hijacking in cancer , 2012, Genome research.
[14] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[15] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[16] Peiyong Jiang,et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. , 2013, Clinical chemistry.
[17] Stephen J. Elledge,et al. Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening , 2008, Science.
[18] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[19] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[20] Rahul C. Deo,et al. Interpreting cancer genomes using systematic host perturbations by tumour virus proteins , 2012, Nature.
[21] Edwin Wang,et al. Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks. , 2013, Seminars in cancer biology.
[22] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[23] E. Wang,et al. Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.
[24] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[25] Hedi Peterson,et al. GraphWeb: mining heterogeneous biological networks for gene modules with functional significance , 2008, Nucleic Acids Res..
[26] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[27] N. Rosenfeld,et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA , 2013, Nature.
[28] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[29] Simo V. Zhang,et al. A map of human cancer signaling , 2007, Molecular systems biology.
[30] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[31] Joshua M. Stuart,et al. Subtype and pathway specific responses to anticancer compounds in breast cancer , 2011, Proceedings of the National Academy of Sciences.
[32] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[33] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[34] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[35] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[36] A. Sivachenko,et al. Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.
[37] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[38] Kevin R Brown,et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. , 2012, Cancer discovery.
[39] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.